Edwards Lifesciences Corp (NYSE:EW)
$ 88.73 -1.38 (-1.53%) Market Cap: 53.46 Bil Enterprise Value: 53.30 Bil PE Ratio: 38.24 PB Ratio: 7.51 GF Score: 98/100

Q4 2022 Edwards Lifesciences Corp Earnings Call Transcript

Jan 31, 2023 / 10:00PM GMT
Release Date Price: $76.7 (+0.84%)
Operator

Greetings, and welcome to the Edwards Lifesciences Fourth Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. (Operator Instructions) Please note, this conference is being recorded.

I will now turn the conference over to our host, Mark Wilterding, Senior Vice President of Investor Relations and Treasurer. Thank you. You may begin.

Mark Wilterding
Edwards Lifesciences Corporation - VP of IR

Thank you very much, Diego, and good afternoon, and thank you all for joining us today. With me on today's call are Mike Mussallem, Chairman and Chief Executive Officer; and Scott Ullem, our Chief Financial Officer. Also joining us for the Q&A portion of the call are Bernard Zovighian, President of Edwards Life Sciences; Larry Wood, our global leader of TAVR and Surgical Structural Heart; Daveen Chopra, our global leader of TMTT and Katie Zimon, our Global Leader of Critical Care.

Just after the close of regular trading, Edwards Lifesciences

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot